0001209191-13-050003.txt : 20131031
0001209191-13-050003.hdr.sgml : 20131031
20131031160912
ACCESSION NUMBER: 0001209191-13-050003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131029
FILED AS OF DATE: 20131031
DATE AS OF CHANGE: 20131031
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6173416100
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Connolly Thomas
CENTRAL INDEX KEY: 0001453943
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 131182826
MAIL ADDRESS:
STREET 1: 717 FIFTH AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-10-29
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001453943
Connolly Thomas
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE,
MA
02139
0
1
0
0
SVP, Human Resources
Common Stock
2013-10-29
4
M
0
938
53.74
A
5940
D
Common Stock
2013-10-29
4
S
0
100
72.68
D
5840
D
Common Stock
2013-10-29
4
S
0
1000
75.00
D
4840
D
Common Stock
2013-10-29
4
S
0
588
75.50
D
4252
D
Common Stock
150
I
401(k)
Stock Option (right to buy)
53.74
2013-10-29
4
M
0
938
0.00
D
2022-09-03
Common Stock
938
11250
D
Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $75.00 (range $74.32 to $75.24).
Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $75.50 (range $75.39 to $75.60).
The option vests in 16 quarterly installments from 09/04/2012.
Kenneth L. Horton, Attorney-In-Fact
2013-10-31